Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Figure 5 ISOX and vorinostat partially restore splicing pattern in DM1 patient-derived fibroblasts. (A) ISOX and vorinostat partially rescue mis-splicing.
Volume 7, Issue 5, Pages (November 2016)
Volume 8, Issue 3, Pages (March 2017)
Volume 16, Issue 3, Pages (March 2008)
Volume 22, Issue 7, Pages (July 2015)
Mouse Models in Preclinical Studies for Pachyonychia Congenita
Volume 25, Issue 9, Pages (September 2017)
Volume 12, Issue 10, Pages (September 2015)
Brca1 Controls Homology-Directed DNA Repair
Volume 8, Issue 4, Pages (April 2017)
Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Volume 154, Issue 6, Pages (September 2013)
Volume 7, Issue 1, Pages (April 2014)
Molecular Therapy - Nucleic Acids
Volume 13, Issue 2, Pages (October 2015)
Genome Engineering with CRISPR-Cas9 in the Mosquito Aedes aegypti
Molecular Therapy - Nucleic Acids
Volume 7, Issue 3, Pages (September 2016)
Molecular Therapy - Nucleic Acids
Volume 7, Issue 5, Pages (November 2016)
Volume 13, Issue 6, Pages (December 2013)
RNA-Guided Genome Editing in Plants Using a CRISPR–Cas System
Volume 8, Issue 3, Pages (March 2017)
Molecular Therapy - Nucleic Acids
Andrew R. Bassett, Charlotte Tibbit, Chris P. Ponting, Ji-Long Liu 
Imprinting at the SMPD1 Locus: Implications for Acid Sphingomyelinase–Deficient Niemann-Pick Disease  Calogera M. Simonaro, Jae-Ho Park, Efrat Eliyahu,
Volume 154, Issue 6, Pages (September 2013)
Volume 10, Issue 6, Pages (June 2018)
Volume 1, Issue 3, Pages (September 2013)
Current Progress in Therapeutic Gene Editing for Monogenic Diseases
Expression of a microRNA-Resistant Target Transgene Misrepresents the Functional Significance of the Endogenous microRNA: Target Gene Relationship  Junyan.
Volume 9, Issue 6, Pages (December 2017)
RAD51 is essential for L. donovani.
Unlinking an lncRNA from Its Associated cis Element
Volume 9, Issue 4, Pages (November 2014)
Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases  Li Xu, Piming Zhao, Andrew Mariano, Renzhi.
GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9- mediated Genome Editing  Astrid Glaser, Bradley McColl, Jim Vadolas  Molecular.
Volume 10, Issue 2, Pages (February 2018)
Volume 11, Issue 6, Pages (May 2015)
Volume 2, Issue 1, Pages (January 2014)
Volume 25, Issue 1, Pages (January 2017)
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Molecular Therapy - Methods & Clinical Development
Olivier Humbert, Nancy Maizels  Molecular Therapy - Nucleic Acids 
Molecular Therapy - Nucleic Acids
Volume 25, Issue 2, Pages (February 2017)
Molecular Therapy - Nucleic Acids
Correct mRNA Processing at a Mutant TT Splice Donor in FANCC Ameliorates the Clinical Phenotype in Patients and Is Enhanced by Delivery of Suppressor.
Volume 9, Issue 3, Pages (September 2017)
Mouse Models in Preclinical Studies for Pachyonychia Congenita
Assessing the Functional Characteristics of Synonymous and Nonsynonymous Mutation Candidates by Use of Large DNA Constructs  A.M. Eeds, D. Mortlock, R.
Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii. Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii.
CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients  Claudia Provenzano,
Volume 16, Issue 2, Pages (February 2015)
Natalay Kouprina, Vladimir Larionov 
Sugar Receptors in Drosophila
Fig. 4 Gene disruption via chip.
Volume 2, Issue 6, Pages (June 2014)
Volume 5, Issue 5, Pages (November 2015)
Molecular Therapy - Nucleic Acids
Fig. 2 Cas9/RecA-mediated in vivo gene correction of Pde6b.
Volume 26, Issue 11, Pages (November 2018)
Molecular Therapy - Nucleic Acids
Volume 9, Issue 4, Pages (April 2016)
Exon Skipping in IVD RNA Processing in Isovaleric Acidemia Caused by Point Mutations in the Coding Region of the IVD Gene  Jerry Vockley, Peter K. Rogan,
Volume 10, Issue 2, Pages (February 2018)
Knock-in of the rpl42-P56Q mutation using the split-ura4 system.
Presentation transcript:

Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts Sara E. Howden, John P. Maufort, Bret M. Duffin, Andrew G. Elefanty, Edouard G. Stanley, James A. Thomson  Stem Cell Reports  Volume 5, Issue 6, Pages 1109-1118 (December 2015) DOI: 10.1016/j.stemcr.2015.10.009 Copyright © 2015 The Authors Terms and Conditions

Figure 1 Episomal Reprogramming System Is Enhanced with Inclusion of Plasmid Encoding the miR302/367 Cluster Reprogramming experiments were performed with and without inclusion of the miR302/367 expression plasmid using a normal male fibroblast line. Data represent an average of three independent experiments ± SD. Stem Cell Reports 2015 5, 1109-1118DOI: (10.1016/j.stemcr.2015.10.009) Copyright © 2015 The Authors Terms and Conditions

Figure 2 Gene Targeting of the DNMT3B Locus (A) Schematic diagram of the DNMT3B locus and the donor template used for gene targeting. pA, polyA signal; Ex, exon. (B) Flow cytometric analysis of H9 cells 3 days following the transfection of DNMT3B-specific donor template, mRNA encoding Cas9 protein, and plasmid carrying DNMT3B-specific sgRNA. (C) Representative phase contrast and fluorescent images of an iPS cell colony generated after simultaneous reprogramming and gene targeting of DNMT3B in fibroblasts derived from a patient with retinitis pigmentosa, acquired 2.5 weeks post-electroporation. (D) Flow cytometric analysis of the total cell population after EDTA passaging, initiated approximately 3 weeks post-electroporation. Analysis was performed after three and five passages. (E) PCR analysis across recombination junction to confirm gene targeting of DNMT3B, using primers specific to sequence upstream of 3′ homology arm and EGFP. Analysis was performed on 6 EGFP-expressing iPS cell clones (lanes G1–G6) and 6 EGFP-non-expressing iPS cell clones (lanes C1–C6). An H9-derived DNMT3B-EGFP knockin and BAC carrying EGFP inserted at DNMT3B start codon (used to generate donor template) were included as positive controls. (F) Flow cytometric analysis of EGFP-expressing iPS cell lines generated after simultaneous reprogramming and gene targeting of the DNMT3B locus. Stem Cell Reports 2015 5, 1109-1118DOI: (10.1016/j.stemcr.2015.10.009) Copyright © 2015 The Authors Terms and Conditions

Figure 3 Simultaneous Reprogramming and Genetic Correction of the PRPF8 Gene in Fibroblasts from a Patient with Retinitis Pigmentosa (A) Schematic diagram of the PRPF8 gene, with mutation in exon 42. The Cas9 target site (red), the patient-specific mutation (blue), and antisense single-stranded DNA template used for gene repair are shown. (B) Sequencing analysis of exon 42 of the PRPF8 gene in the genomic DNA from uncorrected patient-specific iPS cells. Both wild-type and mutant alleles are shown. (C) Sequencing analysis of genomic DNA from a single iPS cell clone following successful simultaneous reprogramming and genetic correction of patient-specific fibroblasts. Both alleles appear to have undergone homologous recombination with the corrective ssODN as evidenced by the presence of the ssODN-specific synonymous mutations (SM 1-4) on both alleles. One allele also has a single base-pair deletion, which is most likely caused by an ssODN that was incorrectly synthesized. The location of the patient-specific mutation and synonymous mutations introduced by the repair ssODN are marked by black boxes. Stem Cell Reports 2015 5, 1109-1118DOI: (10.1016/j.stemcr.2015.10.009) Copyright © 2015 The Authors Terms and Conditions

Figure 4 Simultaneous Reprogramming and Genetic Correction of ADA-SCID Fibroblasts (A) Schematic diagram of the ADA gene, with mutation in exon 11. The Cas9 target site (red), the patient-specific mutation (blue), and antisense single-stranded DNA template used for gene repair are shown. (B) Sequencing analysis of exon 11 of the ADA gene in the genomic DNA of an uncorrected and two gene-corrected iPS cell lines derived from ADA-SCID fibroblasts. One of the gene-corrected lines (clone Bb) was also found to carry a G > A transition approximately 35 bp downstream of the intended DNA double-stranded break, and most likely introduced by an incorrectly synthesized ssODN. (C) Sequencing analysis of the ADA transcript amplified from the cDNA of an uncorrected and two gene-corrected iPS cell lines. The location of the patient-specific mutation, synonymous mutation, and G > A transition introduced by the repair ssODN are marked by black boxes. Stem Cell Reports 2015 5, 1109-1118DOI: (10.1016/j.stemcr.2015.10.009) Copyright © 2015 The Authors Terms and Conditions

Figure 5 Sequencing Analysis of Oligonucleotides Used in Gene Repair Experiments The number of plasmid clones (expressed as percentage of total clones analyzed) carrying oligonucleotide sequence with at least one mutational event is shown. As a control, the PRPF8-specific oligonucleotide sequence from a single plasmid clone was PCR-amplified and re-cloned to assess polymerase error rate. Stem Cell Reports 2015 5, 1109-1118DOI: (10.1016/j.stemcr.2015.10.009) Copyright © 2015 The Authors Terms and Conditions